Thermo Fisher stops sale of DNA kits in Tibet after activists raised fears of rights abuses

Campaigners say testing is among methods used to surveil people in the tightly controlled region

The US biotech company Thermo Fisher has halted sales of its DNA identification kits in Tibet, nearly five years after it made a similar commitment about the sale of its products in the neighbouring western Chinese region of Xinjiang.

It decided to stop sales in Tibet after months of complaints from rights groups and investors that the technology may be used in a way that abuses human rights. The company said that the decision was made in the middle of 2023, but it was only revealed to investors late last month.

Continue reading...

UK and Europe are falling behind US and China in biotech, says AstraZeneca boss

Pascal Soriot says decline in startups across Europe differs markedly from ‘explosion’ of firms and clinical trials in China

The boss of Britain’s biggest drugmaker has said that the UK and the rest of Europe are falling behind China and the US in the creation of biotech firms and clinical trials of new medicines.

Pascal Soriot, chief executive of AstraZeneca, said that while China had seen an “explosion of biotech companies”, and a “rapid expansion of clinical trials” that puts it ahead of the US, the UK and EU had posted declines.

Continue reading...

If they could turn back time: how tech billionaires are trying to reverse the ageing process

Jeff Bezos and Peter Thiel are pouring huge sums into startups aiming to keep us all young – or even cheat death. And the science isn’t as far-fetched as you might think

In the summer of 2019, months before the word “coronavirus” entered the daily discourse, Diljeet Gill was double-checking data from his latest experiment. He was investigating what happens when old human skin cells are “reprogrammed” – a process used in labs around the world to turn adult cells (heart, brain, muscle and the like) – into stem cells, the body’s equivalent of a blank slate.

Gill, a PhD student at the Babraham Institute near Cambridge, had stopped the reprogramming process midway to see how the cells responded. Sure of his findings, he took them to his supervisor, Wolf Reik, a leading authority in epigenetics. What Gill’s work showed was remarkable: the aged skin had become more youthful – and by no small margin. Tests found that the cells behaved as if they were 25 years younger. “That was the real wow moment for me,” says Reik. “I fell off my chair three times.”

Continue reading...

Djokovic-backed ‘biotech’ firm’s approach likened to homeopathy

Exclusive: QuantBioRes says it designs treatments for viral diseases based on electromagnetic frequency

A Danish “biotech” company in which Novak Djokovic holds a majority stake is working on a “frequency” treatment for Covid-19 that an expert says bears similarities to the principles of homeopathy.

The world No 1 men’s tennis player was forced to leave Australia on Sunday after the country’s immigration minister cancelled his visa on the basis that his presence in Australia might risk “civil unrest” as he is a “talisman of anti-vaccination sentiment”.

Continue reading...

UK firm to trial T-cell Covid vaccine that could give longer immunity

Exclusive: Oxfordshire-based Emergex gets go-ahead for trials in Switzerland for skin patch vaccine

An Oxfordshire-based company will soon start clinical trials of a second-generation vaccine against Covid-19, an easy-to-administer skin patch that uses T-cells to kill infected cells and could offer longer-lasting immunity than current vaccines.

Emergex was set up in Abingdon in 2016 to develop T-cell vaccines, the brainchild of Prof Thomas Rademacher, the firm’s chief executive and professor emeritus of molecular medicine at the University College London medical school.

Continue reading...